Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers

  • Why depression and aging are linked to increased disease risk

  • Birth season affects your mood in later life, new research suggests

  • Highly Connected CEOs More Likely to Broker Mergers and Acquisitions That Harm Firms

  • Irritable bowel syndrome: Males report more social stress than females

  • New test to help brain injury victims recover

  • Panic attacks associated with fear of bright daylight

  • Fish intake associated with boost to antidepressant response

  • Aspirin shown to benefit schizophrenia treatment

  • American Alzheimer's plan milestones must be strengthened to meet goal by 2025, experts say

  •